Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone to Prevent PTSD After Traumatic Birth
NCT04852458Phase 1Completed
- Sponsor
- University of Michigan
- Start
- May 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of hydrocortisone in post-traumatic stress disorder (PTSD) (2 arms), sponsored by University of Michigan. Primary endpoint: Posttraumatic Stress Disorder assessed by the City Birth Trauma Scale at 6 weeks. Started May 2021; status: completed.
02
Drugs
hydrocortisone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT04852458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04852458.